EMG
STML

Ellington Management Group’s Stemline Therapeutics, Inc. STML Stock Holding History

Ellington Management Group’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-17,400
Closed -$160K – 938
2017
Q2 		$160K Buy
+17,400
New +$160K 0.02% 558